SpaceX is gearing up for a highly anticipated IPO in June, with Bloomberg estimating a staggering valuation of over $2 trillion. This would position SpaceX among the largest public companies globally. However, investors may want to weigh the potential risks associated with buying into a mature company that is experiencing a slowdown in growth—projected revenue growth is expected to drop from 64% in 2024 to 18% in 2025.
In contrast, RocketLab (RKLB), with a market cap of just $37 billion, presents a compelling alternative for growth-oriented investors. The company is less mature and has significant upside potential, particularly with its upcoming Neutron rocket, which aims to compete with SpaceX’s Falcon. However, RocketLab faces its own challenges, including delays in the Neutron program and a high price-to-sales ratio of 58, far exceeding the S&P 500 average.
Ultimately, while SpaceX’s IPO may attract significant attention, RocketLab offers a more dynamic growth profile, albeit with its own set of risks. Investors should consider waiting for a more favorable entry point before committing to either stock.
Source: fool.com